https://european-biotechnology.net/wp-content/uploads/2026/02/igor-omilaev-t4dYnNOUOWc-unsplash-2-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-18 09:09:102026-02-18 09:09:10Compass Pathways clears second phase III hurdle for psilocybin in treatment-resistant depression
https://european-biotechnology.net/wp-content/uploads/2026/02/george-c-awmdBIp6IO4-unsplash-2-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-17 13:08:532026-02-17 13:08:53Newron secured €38m to test a potential new class in schizophrenia
https://european-biotechnology.net/wp-content/uploads/2026/02/zyanya-citlalli-wBRYgdB3qIs-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-17 12:32:212026-02-17 12:32:21Biotech Beactica and research institute LISCO secured €2.5M to advance glioblastoma therapy to the clinic
https://european-biotechnology.net/wp-content/uploads/2026/02/Team_Immunic.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 16:06:422026-02-13 16:06:42Immunic secured US$400 million to conclude phase 3 MS program and prepare for launch
https://european-biotechnology.net/wp-content/uploads/2026/02/glen-rushton-Uwl7TRuTZqE-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 13:01:002026-02-13 13:01:00Amgen wins European approval to challenge argenx and UCB for autoimmune market
https://european-biotechnology.net/wp-content/uploads/2026/02/wesley-tingey-ak5yDsh1kDQ-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 12:48:472026-02-13 12:48:47GENFIT to receive $20M milestone from Ipsen as Iqirvo tops $200M in first full year
https://european-biotechnology.net/wp-content/uploads/2026/02/maryna-yazbeck-pyzjoMvyCmw-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-12 16:08:532026-02-12 16:08:53Europe’s life sciences investors step up as biotech financing gap widens
https://european-biotechnology.net/wp-content/uploads/2026/02/vedrana-filipovic-jxqTaXF5WmY-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-12 15:39:402026-02-12 15:39:40Zeon invests in Chemify to cut compound synthesis time using AI and robotics
